BC Cancer Agency

Kelowna, British Columbia V1Y5L3

0 studies enrolling now · 2 studies all time

What they study most

HER2 Positive Breast Cancer, Ovarian Cancer

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer — Stopped early